Article

Formulation, Development and Evaluation of Etoricoxib Nanosize Microemulsion Based Gel for Topical Drug Delivery

Vania Rachael Fonseca1, Prashant Jivaji Bhide1★, Madhusudan Purushottam Joshi1★ Corresponding author

  1. 1Department of Pharmaceutics, Goa College of Pharmacy, 18th June Road, Panaji, Goa, INDIA.

CORRESPONDENCE

Prashant Jivaji Bhide

Department of Pharmaceutics, Goa College of Pharmacy, 18th June Road, Panaji, Goa, INDIA.

pjbhide_2000@yahoo.com

Received: 21-02-2019; Revised: 04-09-2019; Accepted: 28-10-2019.

Volume 53, Issue 4S · pp. s571–s579 · PUBLISHED 2019 · DOI: 10.5530/ijper.53.4s.152

View on IJPER original site ↗

ABSTRACT

Introduction: Etoricoxib is a poorly water-soluble oral NSAID and is associated with a number of complications such as bleeding, ulcers and dyspepsia but these can be overcome by delivering the drug topically. Objectives: Microemulgel for the topical delivery of etoricoxib was formulated to increase its solubility and thus improve the skin permeability. Methods: The solubility of etoricoxib was studied in various oils, surfactants and cosurfactants. Pseudo-ternary phase diagrams were constructed by varying the surfactant to cosurfactant (Smix) ratio. Microemulsions with different compositions were formulated and optimized. Selected o/w microemulsions contained 1% etoricoxib and were evaluated for pH, rheology, drug content, particle size and in vitro drug release. Optimized microemulsion was incorporated in 1% Carbopol® 934 and was evaluated for rheological properties, spreadability, in vitro permeation, skin irritation and stability. Results: Capryol™ 90, Tween 80 and Transcutol® P exhibited the highest solubility. Maximum microemulsion region was observed when the Smix ratio was 3:1. The average particle size of the optimized microemulsion was 37.61 nm, zeta potential was -2.88 mV and permeability of the drug from the microemulsion was 66.8% after 8 h. The prepared gel showed 57.8% drug release after 8 hr. Skin irritation studies indicated that the optimized formulation was safe for topical application. Stability studies indicated that the formulation remained unaffected at accelerated storage conditions. Conclusion: Results indicated that the micro-emulgel has potential for sustained action of drug release and may act as a promising tool to enhancepercutaneous delivery of etoricoxib.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Fonseca, V. R., Bhide, P. J., & Joshi, M. P. (2019). Formulation, Development and Evaluation of Etoricoxib Nanosize Microemulsion Based Gel for Topical Drug Delivery. Indian Journal of Pharmaceutical Education and Research, 53(4S), s571–s579. https://doi.org/10.5530/ijper.53.4s.152